These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8549315)

  • 21. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
    Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC; Foleno BD; Fu KP
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Croisier D; Chavanet P; Lequeu C; Ahanou A; Nierlich A; Neuwirth C; Piroth L; Duong M; Buisson M; Portier H
    J Antimicrob Chemother; 2002 Sep; 50(3):349-60. PubMed ID: 12205059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual inhibitory activity of sitafloxacin (DU-6859a) against DNA gyrase and topoisomerase IV of Streptococcus pneumoniae.
    Onodera Y; Uchida Y; Tanaka M; Sato K
    J Antimicrob Chemother; 1999 Oct; 44(4):533-6. PubMed ID: 10588315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms.
    Nagai K; Hoellman D; Davies T; Jacobs M; Appelbaum P
    Clin Microbiol Infect; 2001 Dec; 7(12):703-5. PubMed ID: 11843916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.
    Tomizawa H; Tateda K; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1998 Jan; 41(1):103-6. PubMed ID: 9511043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.
    Morrissey I; Smith JT
    Drugs; 1995; 49 Suppl 2():228-9. PubMed ID: 8549312
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro activity of novel fluoroquinolones against Streptococcus pneumoniae isolated from children with acute otitis media.
    Yagupsky P; Katz O; Peled N; Dagan R
    Chemotherapy; 2001; 47(5):354-8. PubMed ID: 11561138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.
    Karlowsky JA; Nealy L; Sahm DF; Thornsberry C; Jones ME
    J Clin Microbiol; 2001 Jul; 39(7):2748-50. PubMed ID: 11446362
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1997 May; 41(5):1193-5. PubMed ID: 9145900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
    Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.
    Wortmann GW; Bennett SP
    Clin Infect Dis; 1999 Dec; 29(6):1599-600. PubMed ID: 10585837
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae.
    Bauernfeind A
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():77-82. PubMed ID: 10404343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipneumococcal activity of BMS 284756 compared to those of six other agents.
    Pankuch GA; Nagai K; Davies TA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Jan; 46(1):251-4. PubMed ID: 11751147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
    Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1996 May; 25(1):47-51. PubMed ID: 8831045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2431-3. PubMed ID: 8891160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
    Plouffe JF
    Diagn Microbiol Infect Dis; 1996 May; 25(1):43-5. PubMed ID: 8831044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.